Vanguard Group Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 125,856,664 shares of DNA stock, worth $40.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,856,664

Previous 132,780,095 5.21%

Holding current value

$40.3 Million

Previous $224 Million 34.94%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.06 - $1.67 $7.34 Million - $11.6 Million	-6,923,431 Reduced 5.21%	125,856,664 $146 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $583,500 - $828,941	463,096 Added 0.35%	132,780,095 $224 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $6.47 Million - $10.2 Million	4,016,221 Added 3.13%	132,316,999 $239 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $19.8 Million - $33.9 Million	17,409,445 Added 15.7%	128,300,778 $239 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $11.2 Million - $20.5 Million	9,370,053 Added 9.23%	110,891,333 $147 Million

Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $25.5 Million - $55.1 Million	15,646,253 Added 18.22%	101,521,280 $172 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $627,803 - $3.22 Million	-860,005 Reduced 0.99%	85,875,027 $268 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $126 Million - $241 Million	57,401,650 Added 195.69%	86,735,032 $206 Million
Q1 2022 May 13, 2022	SELL	$2.83 - $8.69 $602,011 - $1.85 Million	-212,725 Reduced 0.72%	29,333,382 $118 Million
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $246 Million - $441 Million	29,546,107 New	29,546,107 $246 Million

Others Institutions Holding DNA

# of Institutions

360

Shares Held

1.26B

Call Options Held

845K

Put Options Held

2.54M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $412M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ginkgo Bioworks Holdings, Inc. Transaction History